PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
Radiat Oncol J. 2022;40(1):20-28.   Published online 2022 Mar 25     DOI: https://doi.org/10.3857/roj.2021.00934
Citations to this article as recorded by Crossref logo
PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients
Tanita Suttichaimongkol, Manoon Mitpracha, Kawin Tangvoraphonkchai, Phuangphaka Sadeea, Kittisak Sawanyawisuth, Wattana Sukeepaisarnjaroen
Journal of Circulating Biomarkers.2023; 12: 12.     CrossRef
External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion
Jeong Il Yu, Hee Chul Park, Hyunju Shin, Hyunki Park, Sung Wook Shin, Sung Ki Cho, Dongho Hyun, Jaeseung Shin, Myung Ji Goh, Moon Seok Choi, Boram Park, Sang Min Yoon, Jinhong Jung
Radiotherapy and Oncology.2023; 187: 109841.     CrossRef
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
Tae Hyun Kim, Bo Hyun Kim, Joong-Won Park, Yu Ri Cho, Young-Hwan Koh, Jung Won Chun, Eun Sang Oh, Do Yeul Lee, Sung Uk Lee, Yang-Gun Suh, Sang Myung Woo, Sung Ho Moon, Sang Soo Kim, Woo Jin Lee
Cancers.2022; 14(18): 4445.     CrossRef